| Dr James E Yoder, MD | |
|
935 Pennsylvania Ave Nw, Hcpu/rm 6344, Washington, DC 20535-0001 | |
| (202) 324-4976 | |
| (202) 324-2923 |
| Full Name | Dr James E Yoder |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 935 Pennsylvania Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003195447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | D47887 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James E Yoder, MD 935 Pennsylvania Ave Nw, Hcpu/rm 6344, Washington, DC 20535-0001 Ph: (202) 324-4976 | Dr James E Yoder, MD 935 Pennsylvania Ave Nw, Hcpu/rm 6344, Washington, DC 20535-0001 Ph: (202) 324-4976 |
News Archive
The recommendations of a federal task force on preventive care - once just suggestions for doctors - will soon become coverage requirements for private insurers under regulations unveiled Wednesday by the Obama administration, according to Kaiser Health News and The Washington Post. "Under the new health care overhaul law, insurers will be required to pay fully for services that get an "A" or "B" recommendation from the U.S. Preventive Services Task Force, a volunteer group made up of primary care and public health experts."
An optical fiber probe can distinguish cancer tissue and normal tissue at the margins of a tumor being excised, in real time, by detecting the difference in pH between the two types of tissue.
Syneron Medical Ltd., a leading medical aesthetic device innovator, is announcing their new VelaBABE promotion for women who want to reclaim their pre-baby body with help from VelaShape.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
› Verified 4 days ago
Dr. Dawn Cannon, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5225 Wisconsin Ave Nw Ste 402, Washington, DC 20015 Phone: 202-237-7000 | |
Dr. Richard Kevin Luger, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1760 Af Pentagon Rm 4a870, Washington, DC 20330 Phone: 036-973-2557 Fax: 703-614-1663 | |
Dr. Thomas M Hall, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1660 Columbia Rd Nw, Columbia Road Health Center, Washington, DC 20009 Phone: 202-328-3717 | |
Dr. Jaspal Ahluwalia, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Comdt, Uscg Hq (cg-1122), Us Coast Guard Stop 7907, Martin Luther King Jr Avenue Se, Washington, DC 20598 Phone: 703-872-6629 | |
Dr. Brian Winford Amy, MD,MPH,FACS,FACPM Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 899 N Capitol St Ne Ste 5, Washington, DC 20002 Phone: 202-631-0766 | |
Dr. Patricia Anne Bray, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Constitution Avenue Nw, Osha-department Of Labor Room N3457, Washington, DC 20210 Phone: 202-693-2005 Fax: 202-693-1647 |